RGS RGS Healthcare Solutions

Tender glossary

Supplementary protection certificate (SPC)

Also known as: SPC

Definition

A supplementary protection certificate extends patent-like protection for a medicine in an EU country by up to five years after the patent expires, to make up for the time spent on regulatory approval.

In practice

For generic and biosimilar companies the SPC expiry, not the patent expiry, usually sets the earliest launch and the first tender a new entrant can bid in. Dates differ by country, so the first tenders open to generics are often staggered across Europe.

Example

The patent on a molecule expires in 2027, but an SPC extends protection in most EU countries into 2029. The first tender a generic can bid in follows the SPC date, country by country.

Back to the glossary

See how this plays out in your own tenders

RGS tracks tenders and awards across Europe and applies these rules automatically.